Q2 Earnings Estimate for REGENXBIO Issued By Leerink Partnrs
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for shares of REGENXBIO in a research note issued on Monday, May 12th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings of ($1.47) per share for the quarter, up […]
